Literature DB >> 7291952

Pharmacokinetics of ketoprofen in patients with chronic renal failure.

G Stafanger, H W Larsen, H Hansen.   

Abstract

The pharmacokinetics of ketoprofen were studied in 7 volunteers and in 5 patients suffering from varying degrees of renal insufficiency. All the subjects received a single oral dose (50 mg) of ketoprofen. Plasma concentrations were measured up to 24 hours after administration and urinary excretion for 2 days. Ketoprofen concentrations were determined by mass-fragmentography with a minimum level of detection of 0.02 mg/l. As expected, a reduction of the [51Cr]EDTA clearance was correlated with an increase in the elimination half-life of ketoprofen. The urinary excretion corresponded to results reported by other groups.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7291952     DOI: 10.3109/03009748109095297

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  12 in total

Review 1.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

2.  Stereoselective disposition of flurbiprofen in uraemic patients.

Authors:  M P Knadler; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1992-04       Impact factor: 4.335

Review 3.  Pharmacokinetics of enantiomers of chiral non-steroidal anti-inflammatory drugs.

Authors:  F Jamali
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Jan-Mar       Impact factor: 2.441

4.  Stereoselective pharmacokinetics of ketoprofen and ketoprofen glucuronide in end-stage renal disease: evidence for a 'futile cycle' of elimination.

Authors:  N G Grubb; D W Rudy; D C Brater; S D Hall
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

5.  Reduced elimination of ketoprofen in the elderly is not necessarily due to impaired glucuronidation.

Authors:  R K Verbeeck; S M Wallace; G R Loewen
Journal:  Br J Clin Pharmacol       Date:  1984-06       Impact factor: 4.335

6.  Pharmacokinetic profile of controlled release ketoprofen in elderly patients.

Authors:  M J Dennis; P C French; P Crome; M Babiker; J Shillingford; R Hopkins
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

Review 7.  Clinical pharmacokinetics of ketoprofen and its enantiomers.

Authors:  F Jamali; D R Brocks
Journal:  Clin Pharmacokinet       Date:  1990-09       Impact factor: 6.447

8.  The disposition of ketoprofen enantiomers in man.

Authors:  B C Sallustio; Y J Purdie; A G Whitehead; M J Ahern; P J Meffin
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

Review 9.  Tenoxicam and renal function.

Authors:  R C Heintz
Journal:  Drug Saf       Date:  1995-02       Impact factor: 5.606

10.  Pharmacokinetics of tenoxicam in patients with impaired renal function.

Authors:  F F Horber; T W Guentert; E Weidekamm; P Heizmann; C Descoeudres; F J Frey
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.